Merus Labs International Inc. Fund Predictions

NASDAQ Stock Exchange

Open Broker Account

$1.30

+0 (+0%)

At Close: Aug 09, 2017

Currently predicting for Mon, 6 May 2024

Trading levels for MSLI

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	1.31	0.513 %
		R2	1.30	0.219 %
		R1	1.30	0.0374 %
Current price:			1.30
	Support	S1	1.29	-0.550 %
		S2	1.29	-0.732 %
		S3	1.29	-1.03 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0	.
		R2	0	.
		R1	0	.
Current price			1.30
	Support	S1	1.19	-8.46%
		S2	1.18	-9.23%
		S3	1.17	-10.00%

MSLI Predictions History

7 years ago
JS predicted that MSLI for 2016-09-06 is going $1.00 (-1.96%)

About Merus Labs International Inc.

Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition of prescription medicines primarily in Canada and Europe. The company offers Sintrom, an anti-coagulant drug for the treatment and prevention of thromboembolism diseases; Emselex/Enablex, a prescription medicine for the treatment of urinary urgency and incontinence for adults; and Salagen, an oral tablet for the treatment of symptoms associated with radi... MSLI Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In